These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 30060980)

  • 1. Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
    Keenan TD; Agrón E; Domalpally A; Clemons TE; van Asten F; Wong WT; Danis RG; Sadda S; Rosenfeld PJ; Klein ML; Ratnapriya R; Swaroop A; Ferris FL; Chew EY;
    Ophthalmology; 2018 Dec; 125(12):1913-1928. PubMed ID: 30060980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24.
    Hwang CK; Agrón E; Domalpally A; Cukras CA; Wong WT; Chew EY; Keenan TDL;
    Ophthalmol Retina; 2021 Feb; 5(2):108-117. PubMed ID: 33075546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report Number 33.
    Agrón E; Domalpally A; Cukras CA; Chew EY; Keenan TDL;
    Ophthalmology; 2024 Feb; 131(2):208-218. PubMed ID: 37717737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.
    Agrón E; Domalpally A; Cukras CA; Clemons TE; Chen Q; Swaroop A; Lu Z; Chew EY; Keenan TDL;
    Ophthalmology; 2023 May; 130(5):488-500. PubMed ID: 36481221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
    Al-Holou SN; Tucker WR; Agrón E; Clemons TE; Cukras C; Ferris FL; Chew EY;
    Ophthalmology; 2015 Dec; 122(12):2490-6. PubMed ID: 26435335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
    ; Papudesu C; Clemons TE; Agrón E; Chew EY
    Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
    Yu JJ; Agrón E; Clemons TE; Domalpally A; van Asten F; Keenan TD; Cukras C; Chew EY;
    Ophthalmology; 2019 Feb; 126(2):261-273. PubMed ID: 30142373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.
    ; Domalpally A; Clemons TE; Danis RP; Sadda SR; Cukras CA; Toth CA; Friberg TR; Chew EY
    Ophthalmology; 2017 Apr; 124(4):479-487. PubMed ID: 28089680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Brader HS; Ying GS; Martin ER; Maguire MG;
    Ophthalmology; 2013 Sep; 120(9):1871-9. PubMed ID: 23622873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40.
    Christakis PG; Agrón E; Klein ML; Clemons TE; Campbell JP; Ferris FL; Chew EY; Keenan TD;
    Ophthalmology; 2020 Jun; 127(6):784-792. PubMed ID: 31899035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15.
    Domalpally A; Danis RP; Trane R; Blodi BA; Clemons TE; Chew EY;
    Ophthalmol Retina; 2018 Oct; 2(10):1021-1027. PubMed ID: 30506012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and progression of geographic atrophy: observations from a population-based cohort.
    Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
    Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
    Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of geographic atrophy and genotype in age-related macular degeneration.
    Klein ML; Ferris FL; Francis PJ; Lindblad AS; Chew EY; Hamon SC; Ott J
    Ophthalmology; 2010 Aug; 117(8):1554-9, 1559.e1. PubMed ID: 20381870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography.
    Yehoshua Z; Rosenfeld PJ; Gregori G; Feuer WJ; Falcão M; Lujan BJ; Puliafito C
    Ophthalmology; 2011 Apr; 118(4):679-86. PubMed ID: 21035861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.